Lexeo Therapeutics, Inc.
LXEO
$5.09
-$0.41-7.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.20M | -20.92M | -20.28M | -26.10M | -32.66M |
| Total Depreciation and Amortization | 546.00K | 538.00K | 530.00K | 510.00K | 501.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.71M | 2.70M | 2.71M | -285.00K | 3.71M |
| Change in Net Operating Assets | -4.21M | -2.40M | -12.51M | -1.34M | 6.73M |
| Cash from Operations | -21.14M | -20.08M | -29.55M | -27.22M | -21.72M |
| Capital Expenditure | -35.00K | 0.00 | -289.00K | -108.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.50M | -101.69M | 35.30M | -39.07M | 15.60M |
| Cash from Investing | 27.46M | -101.69M | 35.01M | -39.17M | 15.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -121.00K | -169.00K | -83.00K | -122.00K | -159.00K |
| Issuance of Common Stock | 2.60M | 153.77M | 135.00K | 80.00M | 170.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.00K | -9.83M | 0.00 | -6.92M | -- |
| Cash from Financing | 2.45M | 143.77M | 52.00K | 72.96M | 11.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.77M | 22.00M | 5.52M | 6.57M | -6.11M |